DOCSLIB.ORG

Australian Public Assessment Report for Misoprostol

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Australian Public Assessment Report for Misoprostol Australian Public Assessment Report for Misoprostol Proprietary Product Name: GyMiso Sponsor: MS Health October 2012 Therapeutic Goods Administration About the Therapeutic Goods Administration (TGA) • The Therapeutic Goods Administration (TGA) is part of the Australian Government Department of Health and Ageing, and is responsible for regulating medicines and medical devices. • TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. • The work of the TGA is based on applying scientific and clinical expertise to decision- making, to ensure that the benefits to consumers outweigh any risks associated with the use of medicines and medical devices. • The TGA relies on the public, healthcare professionals and industry to report problems with medicines or medical devices. TGA investigates reports received by it to determine any necessary regulatory action. • To report a problem with a medicine or medical device, please see the information on the TGA website <www.tga.gov.au>. About AusPARs • An Australian Public Assessment Record (AusPAR) provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve a prescription medicine submission. • AusPARs are prepared and published by the TGA. • An AusPAR is prepared for submissions that relate to new chemical entities, generic medicines, major variations, and extensions of indications. • An AusPAR is a static document, in that it will provide information that relates to a submission at a particular point in time. • A new AusPAR will be developed to reflect changes to indications and/or major variations to a prescription medicine subject to evaluation by the TGA. Copyright© Commonwealth of Australia 2012 This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given specific written permission from the Commonwealth to do so. Requests and inquiries concerning reproduction and rights are to be sent to the TGA Copyright Officer, Therapeutic Goods Administration, PO Box 100, Woden ACT 2606 or emailed to <[email protected]>. AusPAR GyMiso Misoprostol Marie Stopes International Australia Page 2 of 100 PM-2011-01625-3-5 Final 2 October 2012 Therapeutic Goods Administration Contents Introduction to product submission __________________________________________________ 4 Submission details ____________________________________________________________________ 4 Product background __________________________________________________________________ 4 Regulatory Status _____________________________________________________________________ 5 Product Information__________________________________________________________________ 5 II. Quality findings _______________________________________________________________________ 5 Drug Substance _______________________________________________________________________ 5 Drug Product __________________________________________________________________________ 6 Conclusion ____________________________________________________________________________ 8 III. Nonclinical findings _________________________________________________________________ 8 Introduction ___________________________________________________________________________ 8 Pharmacology _________________________________________________________________________ 8 Pharmacokinetics _____________________________________________________________________ 9 Toxicology ____________________________________________________________________________ 10 Nonclinical Summary and Conclusions ____________________________________________ 12 IV. Clinical findings ____________________________________________________________________ 13 Introduction __________________________________________________________________________ 13 Pharmacokinetics ____________________________________________________________________ 15 Pharmacodynamics__________________________________________________________________ 23 Efficacy _______________________________________________________________________________ 27 Safety _________________________________________________________________________________ 46 First Round Benefit-Risk Assessment ______________________________________________ 63 List of Questions _____________________________________________________________________ 65 Second Round Benefit-Risk Assessment ___________________________________________ 65 V. Pharmacovigilance findings _______________________________________________________ 66 Risk Management Plan ______________________________________________________________ 66 Summary of Recommendations ____________________________________________________ 74 VI. Overall conclusion and risk/benefit assessment _____________________________ 75 Quality ________________________________________________________________________________ 75 Nonclinical ___________________________________________________________________________ 76 Clinical ________________________________________________________________________________ 77 Risk Management Plan ______________________________________________________________ 82 Risk-benefit analysis ________________________________________________________________ 83 Outcome ______________________________________________________________________________ 89 Appendix 1. Clinical References _____________________________________________________ 89 Attachment 1. Product Information ____________________________________________ 99 AusPAR GyMiso Misoprostol MS Health Page 3 of 100 PM-2011-01625-3-5 Final 2 October 2012 Therapeutic Goods Administration Introduction to product submission Submission details Type of Submission Extension of indications (New formulation, new indication) Decision: Approved Date of Decision: 7 August 2012 Misoprostol Active ingredient(s): Product Name(s): GyMiso Sponsor’s Name and Address: MS Health1l, GPO Box 1635, Melbourne VIC Dose form(s): Tablet (uncoated, not scored) Strength(s): 200 µg Container(s): Blister pack Pack size(s): 4 x tablets Approved Therapeutic use: GyMiso® is indicated in females of childbearing age for the medical termination of a developing intrauterine pregnancy in sequential combination with a mifepristone 200 mg tablet, up to 49 days of gestation. Route(s) of administration: Oral (PO) or buccal Dosage: 800 µg (4 tablets) ARTG Number (s) 188015 Product background Misoprostol is a prostaglandin E1 analogue. This AusPAR describes an application to register GyMiso, misoprostol 200 µg tablets, which is linked to a related application to register Mifepristone Linepharma 200 mg tablet. A single dose of 800 GyMisio is proposed to be used in combination with the 200 mg mifepristone tablets to achieve termination of pregnancy in women who are up to 49 days of gestation/daysμg of amenorrhoea (DA). The 200 mg mifepristone dose is to be taken 36 to 48 h before the misoprostol dose. Cytotec misoprostol 200 µg tablets are currently registered for use in Australia (ARTG R 63983) for the treatment of acute duodenal and gastric ulcers and for the prevention of stress induced upper gastrointestinal mucosal bleeding and lesions in post surgical patients in intensive care units. GyMiso is new formulation of misoprostol for a new indication. GyMiso is not proposed as a generic medicine with respect to Cytotec and no gastrointestinal indications are proposed for GyMiso. 1 The Applicant Marie Stopes International Australia has transferred sponsorship of the registered product to MS Health. AusPAR GyMiso Misoprostol MS Health Page 4 of 100 PM-2011-01625-3-5 Final 2 October 2012 Therapeutic Goods Administration The approved regimen for Cytotec® for gastrointestinal indications involves a total daily longer. dose of 800 μg, taken in divided doses for periods of 14 days up to 12 months or even The sponsor proposed the following indication for GyMiso: In adults and adolescents of childbearing age for the medical termination of a developing intrauterine pregnancy in sequential combination with Mifepristone Linepharma 200mg tablet, up to 49 days of gestation. Cytotec® has been widely used off-label internationally and in Australia for many years for this and related gynaecological indications. Other prostaglandins are registered in Australia for obstetric and gynaecological indications as follows: • Gemeprost (Cervagem®; vaginal pessary): For the softening and dilatation of the cervix uteri prior to transcervical, intrauterine operative procedures in the first trimester of pregnancy. Therapeutic termination of pregnancy in patients in the second trimester of gestation. • Dinoprostone (Cervidil®; vaginal pessary): Cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour. • Dinoprostone (Prostin® E2; vaginal pessary): Induction of labour
Load more

Recommended publications
  • Submission to Tas Legislative Council-Final
    Castan Centre for Human Rights Law Monash University Melbourne Submission to the Tasmanian Legislative Council Committee Government Administration A on the provisions of the 1 Reproductive Health (Access to Terminations) Bill 2013 July 2013 Prepared by: Ms Tania Penovic, Lecturer in Law at Monash University and Deputy Director, Castan Centre for Human Rights Law. Dr Ronli Sifris, Lecturer in Law at Monash University and Associate of the Castan Centre for Human Rights Law. 1 Aspects of this submission have been taken from: Ronli Sifris, ‘A Woman’s Right to Choose: Human Rights and Abortion in Australia’ in Paula Gerber and Melissa Castan (eds), Contemporary Human Rights Issues in Australia (Thomson Reuters, 2013) 251-273. 1 Comments on the Reproductive Health (Access to Terminations) Bill The Bill removes abortion services from the Criminal Code Act 1924 and places them within the ambit of medical services. We commend the removal of the crime of abortion from the Criminal Code. This approach to reproductive health services advances the rights of women and is consistent with standards of human rights applicable in Tasmania. Our submission will address a number of provisions of the Bill. We will first consider the removal of the crime of abortion from the Criminal Code in clause 14 of the Bill. We will then provide detailed comments on the Bill, with particular reference to clauses 4 to 9. Clause 14: Removal of the crime of abortion from the Criminal Code The Bill removes the crime of abortion from the Criminal Code and introduces a new framework which regulates abortion as a health matter.
    [Show full text]
  • Abortion, Homosexuality and the Slippery Slope: Legislating ‘Moral’ Behaviour in South Australia
    Abortion, Homosexuality and the Slippery Slope: Legislating ‘Moral’ Behaviour in South Australia Clare Parker BMusSt, BA(Hons) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy, Discipline of History, Faculty of Humanities and Social Sciences, University of Adelaide. August 2013 ii Contents Contents ii Abstract iv Declaration vi Acknowledgements vii List of Abbreviations ix List of Figures x A Note on Terms xi Introduction 1 Chapter 1: ‘The Practice of Sound Morality’ 21 Policing Abortion and Homosexuality 24 Public Conversation 36 The Wowser State 44 Chapter 2: A Path to Abortion Law Reform 56 The 1930s: Doctors, Court Cases and Activism 57 World War II 65 The Effects of Thalidomide 70 Reform in Britain: A Seven Month Catalyst for South Australia 79 Chapter 3: The Abortion Debates 87 The Medical Profession 90 The Churches 94 Activism 102 Public Opinion and the Media 112 The Parliamentary Debates 118 Voting Patterns 129 iii Chapter 4: A Path to Homosexual Law Reform 139 Professional Publications and Prohibited Literature 140 Homosexual Visibility in Australia 150 The Death of Dr Duncan 160 Chapter 5: The Homosexuality Debates 166 Activism 167 The Churches and the Medical Profession 179 The Media and Public Opinion 185 The Parliamentary Debates 190 1973 to 1975 206 Conclusion 211 Moral Law Reform and the Public Interest 211 Progressive Reform in South Australia 220 The Slippery Slope 230 Bibliography 232 iv Abstract This thesis examines the circumstances that permitted South Australia’s pioneering legalisation of abortion and male homosexual acts in 1969 and 1972. It asks how and why, at that time in South Australian history, the state’s parliament was willing and able to relax controls over behaviours that were traditionally considered immoral.
    [Show full text]
  • International Journal Vol.35.6 SEX SELECTIVE ABORTION AS a SOLUTION of SON’S PREFERENCE
    KNOWLEDGE – International Journal Vol.35.6 SEX SELECTIVE ABORTION AS A SOLUTION OF SON’S PREFERENCE Dorina Xhani European University of Tirana, Albania, [email protected] Abstract: This article addresses the phenomenon of sex-selective abortion, which is a social issue that is becoming a major concern for Albanian society. Sex-selective abortion occurs mostly in China, India, Pakistan and the Caucasus as well, which have strong son preference. In terms of definition, sex-selective abortion consists in the elimination of the female sex baby's birth through prenatal sex selection, as the preference for male children. Abortion of female fetus is most common in areas where cultural norms value male children over female children. This has directly resulted in a severe imbalance in the sex ratio at birth (SRB), which constitutes the most significant contributor to the phenomenon referred to as ‘missing girls’, ‘female deficit’ or ‘shortage of girls’. Numerous challenging demographic, sociological, ethical and public policy questions have arisen from the use of sex-selective abortion. It is an issue that is related to abortion rights, severe gender discrimination and maternal healthcare. This paper aims to provide a concise review of sex-selective abortion worldwide, and to compare it with the Albanian context. Data were obtained from the existing international literature to this approach. This thesis is based on several books and studies focused on the sex-selective abortion considering also Albanian researches. Social policy and theoretical view is the focus to this field of study. Sex selective abortion of female fetus is most common in areas where cultural norms value male children over female children.
    [Show full text]
  • Download Download
    HOW THE CRIMINAL LAW IN AUSTRALIA HAS FAILED TO PROMOTE THE RIGHT TO LIFE FOR UNBORN CHILDREN: A NEED FOR UNIFORM CRIMINAL LAWS ON ABORTION ACROSS AUSTRALIA ∗ PATRICK FERDINANDS This article contends that human life has an intrinsic value from the moment of its conception based on its potential use to the community. This value to the community demands protection from the state. However, there is also a need to balance this aim against the legitimate health interests of pregnant women. Abortions should be permitted only in circumstances where the abortion is necessary to preserve the pregnant woman from any serious danger to her physical or mental health. This article shows that the lack of uniformity in Australia’s criminal law in the area of abortion plays a part in unduly undermining the right to life of unborn children. Accordingly, there is a need for effective uniform criminal laws throughout Australia that properly protect the right to life of unborn children and are duly sensitive to the valid health interests of pregnant women that give rise to circumstances justifying abortion. I INTRODUCTION This article seeks to discover whether or not the criminal law in Australia has failed to promote the right to life for unborn children, and if so, how. It will also examine closely the lack of uniformity in Australia’s criminal law in the 1 area of abortion to see if it plays a part in undermining the rights of unborn ∗ BA (Deakin University), LLB (Hons) (Charles Darwin University), Grad.Dip.Leg.Prac (Australian National University), Public Servant, Victoria.
    [Show full text]
  • Induced Abortion in Australia: 2000-2020 Published by Family Planning NSW 328-336 Liverpool Road, Ashfield NSW 2131, Australia Ph
    Publication Information Induced abortion in Australia: 2000-2020 Published by Family Planning NSW 328-336 Liverpool Road, Ashfield NSW 2131, Australia Ph. (02) 8752 4300 www.fpnsw.org.au ABN: 75 000 026 335 © Family Planning NSW 2021 Suggested citation: Wright, S. M., Bateson, D., & McGeechan, K. (2021). Induced abortion in Australia: 2000-2020. Family Planning NSW: Ashfield, Australia. Acknowledgements: Authors: Sarah M. Wright, Research Officer, Family Planning NSW Deborah Bateson, Medical Director, Family Planning NSW Kevin McGeechan, Consultant Biostatistician, Family Planning NSW Internal review: The production of this document would not have been possible without the contributions of the following members of Family Planning NSW staff: Dr Yan Cheng, Senior Research Officer, Family Planning NSW Dr Clare Boerma, Associate Medical Director, Family Planning NSW 1 Contents Data used in this report ____________________________________________________ 3 Key indicators ________________________________________________________________ 3 Primary data sources ___________________________________________________________ 3 Purpose of this report __________________________________________________________ 4 Terms and definitions __________________________________________________________ 4 Data sources and limitations ____________________________________________________ 5 State government abortion notification ______________________________________________________ 5 Medicare Benefits Schedule and Pharmaceutical Benefits Scheme data ___________________________
    [Show full text]
  • The Fight Hidden in Plain Sight
    THE FIGHT HIDDEN IN PLAIN SIGHT SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN CENTRAL AND EASTERN EUROPE AND CENTRAL ASIA Table of contents: Introduction 5 Albania 6 Armenia 14 Belarus 22 Bosnia and Herzegovina 32 Bulgaria 38 Croatia 44 Georgia 52 Kazakhstan 60 Attribution-NonCommercial-NoDerivatives 4.0 International Latvia 64 Introduction: Antonina Lewandowska North Macedonia 68 Proof reading: Joel Henderson Cover and layout design: Julia Karwan-Jastrzębska, Joanna Meuś Moldova 76 ISBN 978-83-88-568-67-1 Published by: ASTRA Network Secretariat Poland 82 Nowolipie 13/15, 00-150, Warsaw, Poland Warsaw, Poland, 2020 Romania 92 Publication of this report was possible due to financial support of International Women’s Health Coalition. Russia 100 Introduction The year 2019 marked ASTRA Network’s 20th international attention, just like Polish Black anniversary of existence. For two decades, we Protest or Slovak Nebudeme Ticho to name have been monitoring the situation of sexual the latest ones, have had the power to stop and reproductive health and rights in Central draconian laws and keep the legislature intact. and Eastern Europe and Central Asia. Our However, Poland and Slovakia are not the only work focuses on supporting grassroot organ- ones that can mobilize the people – similar isations in the region and providing them initiatives, often organized or coordinated with opportunities to forward their work by ASTRA Network member organisations, even further – including the international were attended by tens of thousands in differ- arena. Our members are amazing actors in ent countries of the region as well. Activists their home countries, who do game-chang- defending human rights are fighting relent- ing grassroot work on community organizing, lessly to not let the far-right and religious providing healthcare and education, mobiliz- fundamentalists alter the system.
    [Show full text]
  • The Abortion Rights Debate
    Volume | 402 Justin Healey Edited by Rights Debate The Abortion The VOLUME 402 THE ABORTION RIGHTS DEBATE ISSUES IN SOCIETY Volume | Volume The Abortion 402 Rights Debate Edited by Justin Healey This e-book is subject to the terms and conditions of a non-exclusive and non-transferable SITE LICENCE AGREEMENT between THE SPINNEY PRESS and: St Peter's Collegiate Girls School, Stonyfell, [email protected] First published by PO Box 438 Thirroul NSW 2515 Australia www.spinneypress.com.au © The Spinney Press 2016. COPYRIGHT All rights reserved. Other than for purposes of and subject to the conditions prescribed under the Australian Copyright Act 1968 and subsequent amendments, no part of this publication may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior permission. Inquiries should be directed to the publisher. REPRODUCTION AND COMMUNICATION FOR EDUCATIONAL PURPOSES The Australian Copyright Act 1968 (the Act) allows a maximum of one chapter or 10% of the pages of this work, whichever is the greater, to be reproduced and/or communicated by any educational institution for its educational purposes provided that the educational institution (or the body that administers it) has given a remuneration notice to Copyright Agency Limited (CAL) under the Act. For details of the CAL licence for educational institutions contact: Copyright Agency Limited, Level 11, 66 Goulburn Street Sydney NSW 2000 Telephone: (02) 9394 7600 Fax: (02) 9394 7601 Email: [email protected] REPRODUCTION AND COMMUNICATION FOR OTHER PURPOSES Except as permitted under the Act (for example a fair dealing for the purposes of study, research, criticism or review) no part of this book may be reproduced, stored in a retrieval system, communicated or transmitted in any form or by any means without prior written permission.
    [Show full text]
  • All the Choice and All the Responsibilities: an Exploration of the Agency Perceived by Women with Children Around Their Childbearing
    COPYRIGHT AND USE OF THIS THESIS This thesis must be used in accordance with the provisions of the Copyright Act 1968. Reproduction of material protected by copyright may be an infringement of copyright and copyright owners may be entitled to take legal action against persons who infringe their copyright. Section 51 (2) of the Copyright Act permits an authorized officer of a university library or archives to provide a copy (by communication or otherwise) of an unpublished thesis kept in the library or archives, to a person who satisfies the authorized officer that he or she requires the reproduction for the purposes of research or study. The Copyright Act grants the creator of a work a number of moral rights, specifically the right of attribution, the right against false attribution and the right of integrity. You may infringe the author’s moral rights if you: - fail to acknowledge the author of this thesis if you quote sections from the work - attribute this thesis to another author - subject this thesis to derogatory treatment which may prejudice the author’s reputation For further information contact the University’s Director of Copyright Services sydney.edu.au/copyright ALL THE CHOICES AND ALL THE RESPONSIBILITIES: AN EXPLORATION OF THE AGENCY PERCEIVED BY WOMEN WITH CHILDREN AROUND THEIR CHILDBEARING Donna M. Y. Read Faculty of Rural Management The University of Sydney A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy 2014 For my mum Joyce Louise Read (1925-1999) I miss her every day i ABSTRACT This thesis presents findings from an exploratory study of agency around childbearing perceived by women with children from a feminist perspective.
    [Show full text]
  • Disertacion Albana Poloska 2016
    Disertacion Albana Poloska 2016 REPUBLIKA E SHQIPËRISË UNIVERSITETI I MJEKËSISË FAKULTETI I SHKENCAVE MJEKËSORE TEKNIKE TIRANË PROGRAMI I STUDIMIT TË DOKTORATURËS DISERTACION PËR MARRJEN E GRADËS SHKENCORE ”DOKTOR NË SHKENCAT INFERMIERORE” Tema: PREVALENCA E ABORTEVE NË MOSHAT 15- 45 VJEÇ UDHËHEQËS SHKENCOR PUNOI PROF. DR. GJERGJ THEODHOSI ALBANA POLOSKA TIRANË, 2016 i Disertacion Albana Poloska 2016 REPUBLIKA E SHQIPËRISË UNIVERSITETI I MJEKËSISË FAKULTETI I SHKENCAVE MJEKËSORE TEKNIKE TIRANË PROGRAMI I STUDIMIT TË DOKTORATURËS DISERTACION I PARAQITUR NGA: ZNJ. ALBANA POLOSKA PËR MARRJEN E GRADËS SHKENCORE ”DOKTOR NË SHKENCAT INFERMIERORE” TEMA: PREVALENCA E ABORTEVE NË MOSHAT 15- 45 VJEÇ UDHËHEQËS SHKENCOR PUNOI Prof. Dr. GJERGJ THEODHOSI ALBANA POLOSKA MBROHET ME DATË ......./....... 2016 PARA JURISË 1. Prof. Asc Kiri Zallari (kryetar) 2. Prof Genc Burazeri (oponent) 3. Prof Astrit Bimbashi (oponent) 4. Prof.Asc Gentiana Qirjako (anëtar) 5. Prof.Asc Edmond Pistuli (anëtar) ii Disertacion Albana Poloska 2016 FALENDERIME Falenderimet e mia shkojnë për të gjithë ata që nga afër apo larg më kanë ndihmuar në realizimin e këtij punimi. Falenderoj Prof. Dr. Petrit BARA, Dekanin e Fakultetit të Shkencave Mjekësore Teknike, dhe gjithë stafin e këtij fakulteti të cilët më mundësuan mbrojtjen e Doktoraturës pranë Fakultetit të Shkencave Mjekësore Teknike. Falenderoj udhëheqësin e kësaj teme Prof. Dr. Gjergj Theodhosi, për këshillat, besimin, vlerësimin, përkushtimin dhe mbështetjen që më ka dhënë gjatë punimit të kësaj teme për të realizuar një bashkëpunim të frytshëm në përputhje me objektivin e këtij studimi. E falenderoj Profesorin për durimin dhe qetësinë që e karakterizon i cili më ka ndihmuar dhe inkurajuar që të realizoj një studim me standarte akademike.Mendimet dhe sugjerimet e tij kanë qenë shumë të dobishme dhe ndihmuese për mua gjatë kryerjes së këtij proçesi kërkimor.
    [Show full text]
  • Abortion and the Law in New
    NSW PARLIAMENTARY LIBRARY RESEARCH SERVICE Abortion and the law in New South Wales by Talina Drabsch Briefing Paper No 9/05 ISSN 1325-4456 ISBN 0 7313 1784 X August 2005 © 2005 Except to the extent of the uses permitted under the Copyright Act 1968, no part of this document may be reproduced or transmitted in any form or by any means including information storage and retrieval systems, without the prior written consent from the Librarian, New South Wales Parliamentary Library, other than by Members of the New South Wales Parliament in the course of their official duties. Abortion and the law in New South Wales by Talina Drabsch NSW PARLIAMENTARY LIBRARY RESEARCH SERVICE David Clune (MA, PhD, Dip Lib), Manager..............................................(02) 9230 2484 Gareth Griffith (BSc (Econ) (Hons), LLB (Hons), PhD), Senior Research Officer, Politics and Government / Law .........................(02) 9230 2356 Talina Drabsch (BA, LLB (Hons)), Research Officer, Law ......................(02) 9230 2768 Lenny Roth (BCom, LLB), Research Officer, Law ...................................(02) 9230 3085 Stewart Smith (BSc (Hons), MELGL), Research Officer, Environment ...(02) 9230 2798 John Wilkinson (MA, PhD), Research Officer, Economics.......................(02) 9230 2006 Should Members or their staff require further information about this publication please contact the author. Information about Research Publications can be found on the Internet at: www.parliament.nsw.gov.au/WEB_FEED/PHWebContent.nsf/PHPages/LibraryPublications Advice on
    [Show full text]
  • Woman-Centered, Comprehensive Abortion Care Reference Manual
    Second Edition Woman-Centered, Comprehensive Abortion Care Reference Manual Disclaimer: The regularly updated Clinical Updates in Reproductive Health (www.ipas.org/clinicalupdates) provides Ipas’s most up-to-date clinical guidance, which supersedes any guidance that may differ in Ipas curricula or other materials. ISBN: 1-882220-87-0 © 2005, 2013 Ipas. Produced in the United States of America. Ipas. (2013). Woman-centered, comprehensive abortion care: Reference manual (second ed.) K. L. Turner & A. Huber (Eds.), Chapel Hill, NC: Ipas. Ipas is a nonprofit organization that works around the world to increase women’s ability to exercise their sexual and reproductive rights, especially the right to safe abortion. We seek to eliminate unsafe abortion and the resulting deaths and injuries and to expand women’s access to comprehensive abortion care, including contraception and related reproductive health information and care. We strive to foster a legal, policy and social environment supportive of women’s rights to make their own sexual and reproductive health decisions freely and safely. Ipas is a registered 501(c)(3) nonprofit organization. All contributions to Ipas are tax deductible to the full extent allowed by law. Cover photo credits: © Richard Lord Illustrations: Stephen C. Edgerton The illustrations and photographs used in this publication are for illustrative purposes only. No similarity to any actual person, living or dead, is intended. For more information or to donate to Ipas: Ipas P.O. Box 9990 Chapel Hill, NC 27515 USA 1-919-967-7052 [email protected] www.ipas.org Printed on recycled paper. Ipas Woman-Centered, Comprehensive Abortion Care: Reference Manual Acknowledgments - Second edition This second edition of Ipas’s Woman-Centered, Comprehensive Abortion Care: Reference Manual was revised by the following Ipas staff and consultants: Katherine L.
    [Show full text]
  • Ghazaleh Samandari, Phd MPH Adjunct Assistant Professor, University of North Carolina at Chapel Hill [email protected] • 202-277-3495
    Dr. Ghazaleh Samandari, PhD MPH Adjunct Assistant Professor, University of North Carolina at Chapel Hill [email protected] • 202-277-3495 EDUCATION: The University of North Carolina – Chapel Hill 2010 School of Public Health Degree: PhD in Public Health Minor: Health Behavior and Health Education The George Washington University, Washington, D.C. 2005 School of Public Health and Health Services Degree: Master of Public Health Boston College, Chestnut Hill, MA 2002 School of Arts and Sciences Degree: Bachelor of Arts SKILLS: - Design, implementation and analysis of operations research and project monitoring & evaluation - Development and execution of complex statistical analyses - Quantitative and qualitative research in health communication, health behavior and social marketing - Focus group and in-depth interview design and administration - Knowledgeable in SAS, SPSS, STATA, MPLUS, EXCEL and ACCESS software applications - Topical expertise in Adolescent Sexual and Reproductive Health, Domestic Violence, HIV/AIDS, Malaria, Sexual and Reproductive Health, Human Resources for Health - Proficient in Farsi, conversational in Spanish and French - Professional experience working in multiple international and domestic settings, working effectively both in groups and independently - Highly organized, detail-oriented, flexible, self-motivated - Excellent written and oral communication skills PROFESSIONAL EXPERIENCE: JOHN SNOW, INC. (KMS PROJECT) Washington, DC - Senior Research Analyst 2013-present • Supporting USAID’s seven Element teams:
    [Show full text]